HNMPA-(AM)3 is a cell-permeable and selective insulin receptor tyrosine kinase inhibitor analog of HNMPA. HNMPA-(AM)3 greatly inhibits the ability of prothoracicotropic hormone (PTTH) to activate ERK phosphorylation and stimulate ecdysteroidogenesis. HNMPA-(AM)3 is also effective in inhibiting ecdysteroid production (IC50=14.2 µM) and insulin receptor activity (IC50 is 14.2 µM and 200 µM in mosquitoes and mammals, respectively)[1][2].
Molekulargewicht:
454.36
Reinheit:
98.04
CAS Nummer:
[120944-03-8]
Formel:
C20H23O10P
Target-Kategorie:
Insulin Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten